Skip to main content
Register Here

UNC Project- Malawi Cancer Program

WHY MALAWI? 

The UNC Project- Malawi Cancer Program is well-positioned to catalyze a broad, coordinated cancer control effort in Malawi, and address key scientific questions related to cancer in sub-Saharan Africa. Read More 

OUR PRIORITIES 

We aim to develop sufficient internal capacity such that Malawi can become a leader of cancer care and research in low-resource settings, as it has long been for HIV care and treatment. Read More 

OUR PARTNERS 

Collaboration is an important component of what we do and our success is supported by a remarkable cancer research network of diverse and accomplished partner institutions. Read More 

Recent Scientific Outputs

Recent News

  • Congratulations to the most recently funded pilot grant program awardees!

    Left to right: Micheline Sanderson; Gerald Tegha; Shivani Sud; Maganizo Chagomerana Not pictured: John Chapola; Mako Mulongo Lineberger Comprehensive Cancer Center (LCCC)/UNC Project Malawi Cancer Program Pilot Grant: The UNC Project Malawi Cancer Program has awarded three grants as part of the Mentored Pilot Grant Program funded by the UNC Lineberger Comprehensive Cancer Center (LCCC). … Continued

  • UJMT fogarty fellowship logo

    UJMT Fogarty Global Health Fellowship 2021-2022 Call for Applications

    Since 2012, the University of North Carolina at Chapel Hill, Johns Hopkins University, Morehouse School of Medicine, and Tulane University have offered exceptional global public health training through the UJMT Fogarty Global Health Fellowship program, funded by the Fogarty International Center within the National Institutes of Health. This consortium brings together four top-ranked universities and … Continued

  • New U54 Team for article

    UNC-led Consortium to Study HIV-related Cancers in sub-Saharan Africa

    A team of UNC researchers are partnering with colleagues at four institutions in Africa to study HIV-associated malignancies. With a five-year, $6-million grant from the NIH’s National Cancer Institute, the research consortium will look at screening and diagnosing innovations for three cancers common to people with HIV: Kaposi sarcoma, cervical cancer, and lymphoma.